Value of CXCL8–CXCR1/2 axis in neoadjuvant chemotherapy for triple-negative breast cancer patients: a retrospective pilot study
Ruoxi Wang, Peng Ji, Yue Gong, Zhi‐Ming Shao, Sheng Chen
Topics & Concepts
MedicineInternal medicineBreast cancerCarboplatinOncologyTriple-negative breast cancerChemotherapyRegimenProportional hazards modelNeoadjuvant therapyGastroenterologyCancerPaclitaxelCisplatinChemokine receptors and signalingBreast Cancer Treatment StudiesCancer, Stress, Anesthesia, and Immune Response